TRPA1 as a therapeutic target for nociceptive pain.
Souza Monteiro de Araujo D, Nassini R, Geppetti P, De Logu F.
Expert Opin Ther Targets. 2020 Oct;24(10):997-1008. doi: 10.1080/14728222.2020.1815191. Epub 2020 Sep 11.
Low back pain: guidelines for the clinical classification of predominant neuropathic, nociceptive, or central sensitization pain.
Nijs J, Apeldoorn A, Hallegraeff H, Clark J, Smeets R, Malfliet A, Girbes EL, De Kooning M, Ickmans K.
Pain Physician. 2015 May-Jun;18(3):E333-46.
Neuropathic pain: mechanisms and their clinical implications.
Cohen SP, Mao J.
BMJ. 2014 Feb 5;348:f7656. doi: 10.1136/bmj.f7656.
Deciphering nociplastic pain: clinical features, risk factors and potential mechanisms.
Kaplan CM, Kelleher E, Irani A, Schrepf A, Clauw DJ, Harte SE.
Nat Rev Neurol. 2024 Jun;20(6):347-363. doi: 10.1038/s41582-024-00966-8. Epub 2024 May 16.
Pain Management in CKD: A Guide for Nephrology Providers.
Koncicki HM, Unruh M, Schell JO.
Am J Kidney Dis. 2017 Mar;69(3):451-460. doi: 10.1053/j.ajkd.2016.08.039. Epub 2016 Nov 20.
The concept of nociplastic pain-where to from here?
Kosek E.
Pain. 2024 Nov 1;165(11S):S50-S57. doi: 10.1097/j.pain.0000000000003305.
General Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation.
Yam MF, Loh YC, Tan CS, Khadijah Adam S, Abdul Manan N, Basir R.
Int J Mol Sci. 2018 Jul 24;19(8):2164. doi: 10.3390/ijms19082164.
Uses of fluoxetine in nociceptive pain management: A literature overview.
Barakat A, Hamdy MM, Elbadr MM.
Eur J Pharmacol. 2018 Jun 15;829:12-25. doi: 10.1016/j.ejphar.2018.03.042. Epub 2018 Mar 30.
Pure nociceptive pain is very rare.
Toda K.
Curr Med Res Opin. 2019 Nov;35(11):1991. doi: 10.1080/03007995.2019.1638761. Epub 2019 Aug 2.
Hyperacusis in chronic pain: neural interactions between the auditory and nociceptive systems.
Suhnan AP, Finch PM, Drummond PD.
Int J Audiol. 2017 Nov;56(11):801-809. doi: 10.1080/14992027.2017.1346303. Epub 2017 Jul 7.
